KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$316.0 million.

  • Amgen's Net Cash Flow fell 11066.85% to -$316.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.8 billion, marking a year-over-year decrease of 37638.48%. This contributed to the annual value of -$2.8 billion for FY2025, which is 37638.48% down from last year.
  • According to the latest figures from Q4 2025, Amgen's Net Cash Flow is -$316.0 million, which was down 11066.85% from $1.4 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Net Cash Flow registered a high of $23.9 billion during Q1 2023, and its lowest value of -$23.8 billion during Q4 2023.
  • Over the past 5 years, Amgen's median Net Cash Flow value was -$303.0 million (recorded in 2024), while the average stood at $143.2 million.
  • Per our database at Business Quant, Amgen's Net Cash Flow skyrocketed by 930517.24% in 2021 and then tumbled by 117052.86% in 2023.
  • Quarter analysis of 5 years shows Amgen's Net Cash Flow stood at -$4.0 billion in 2021, then soared by 52.94% to -$1.9 billion in 2022, then crashed by 1170.53% to -$23.8 billion in 2023, then surged by 112.45% to $3.0 billion in 2024, then crashed by 110.67% to -$316.0 million in 2025.
  • Its Net Cash Flow was -$316.0 million in Q4 2025, compared to $1.4 billion in Q3 2025 and -$782.0 million in Q2 2025.